⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26455763 | 0.98 | — | — | |
| SCHEMBL26455751 | 0.86 | — | — | |
| SCHEMBL26455716 | 0.84 | EPHX2 (0.38) | — | |
| SCHEMBL26455766 | 0.84 | — | — | |
| SCHEMBL26455720 | 0.79 | LPAR3 (0.41) | — | |
| SCHEMBL24394423 | 0.79 | LPAR2 (0.33) | — | |
| SCHEMBL26455678 | 0.78 | — | — | |
| SCHEMBL26456508 | 0.78 | — | — | |
| SCHEMBL24394414 | 0.77 | CNR1 (0.43) | — | |
| SCHEMBL26456557 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4577520-A1 | PEGYLATED LIPID COMPOUNDS AND METHODS OF USE THEREOF | Renagade Therapeutics Management Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| EP-4262883-B1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-05-28 | — | — | EP | claimed |
| WO-2024044728-A1 | PEGYLATED LIPID COMPOUNDS AND METHODS OF USE THEREOF | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2024-02-29 | — | — | WO | claimed |
| EP-4262883-A1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2023-10-25 | — | — | EP | claimed |
| WO-2022133344-A1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (US) | 2022-06-23 | — | — | WO | claimed |
| EP-4617367-A2 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2025-09-17 | — | — | EP | disclosed |
| US-20240148663-A1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2024-05-09 | — | — | US | disclosed |
| EP-4262883-A1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (CH) | 2023-10-25 | — | — | EP | disclosed |
| US-20230139594-A1 | CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS | GENEVANT SCIENCES GMBH (CH) | 2023-05-04 | — | — | US | disclosed |
| US-20230139594-A1 | CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS | GENEVANT SCIENCES GMBH (CH) | 2023-05-04 | — | — | US | disclosed |
| WO-2022133344-A1 | PEG LIPIDS AND LIPID NANOPARTICLES | GENEVANT SCIENCES GMBH (US) | 2022-06-23 | — | — | WO | disclosed |